Marsh & McLennan Companies (MMC)
(Delayed Data from NYSE)
$223.32 USD
-2.15 (-0.95%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $223.34 +0.02 (0.01%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$223.32 USD
-2.15 (-0.95%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $223.34 +0.02 (0.01%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Zacks News
Why Is Brown & Brown (BRO) Up 4.9% Since Last Earnings Report?
by Zacks Equity Research
Brown & Brown (BRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Allstate (ALL) Estimates $226M Initial Loss From Hurricane Beryl
by Zacks Equity Research
Allstate's (ALL) estimated catastrophe losses for July are $587 million from 20 events.
Employers Holdings (EIG) Drops 5.8% Despite Q2 Earnings Beat
by Zacks Equity Research
Employers Holdings (EIG) has a leftover capacity of $44.4 million under its repurchase authorization.
Marsh & McLennan (MMC) Upgraded to Buy: Here's Why
by Zacks Equity Research
Marsh & McLennan (MMC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MarketAxess (MKTX) Q2 Earnings Beat on Higher Commissions
by Zacks Equity Research
MarketAxess' (MKTX) second-quarter earnings benefit from improved commissions. However, rising expenses and lesser trading activity of U.S. high-yield partially offset the positives.
The Market's Excessive Recession Fears
by Sheraz Mian
We comment on the ongoing market sell-off, in addition to featuring new research reports on Johnson & Johnson (JNJ), T-Mobile (TMUS) and Marsh & McLennan (MMC) and others.
AMERISAFE (AMSF) Stock Down 5.3% Since Q2 Earnings Miss
by Zacks Equity Research
AMERISAFE's (AMSF) second-quarter earnings suffer from an increase in operating expenses. Improved premiums partially offset the negatives.
Lincoln National (LNC) Q2 Earnings Beat on Annuities Strength
by Zacks Equity Research
Lincoln National's (LNC) second-quarter net income of $895 million grew 75.1% year over year.
Aflac (AFL) Q2 Earnings Beat on Strong Investment Income
by Zacks Equity Research
Aflac's (AFL) second-quarter results benefit from lower benefits and expenses and higher investment income. However, lower net earned premiums in the Japan segment act as a partial offset.
AIG Q2 Earnings Miss Estimates on High Catastrophe Losses
by Zacks Equity Research
AIG's second-quarter results are affected by higher global catastrophe losses. This was partially offset by improved net investment income.
Allstate (ALL) Q2 Earnings Beat on Property-Liability Rate Hikes
by Zacks Equity Research
Allstate (ALL) witnesses lower property and casualty insurance claims and claims expenses in the second quarter.
CNO Financial (CNO) Q2 Earnings Beat Estimates, '24 EPS View Up
by Zacks Equity Research
CNO Financial (CNO) raises its 2024 EPS in the range of $3.30-$3.50, indicating an increase of 10% from the 2023 figure of $3.09.
AON Q2 Earnings Miss Estimates on Higher Benefit Expenses
by Zacks Equity Research
AON's second-quarter results reflect elevated operating expenses, partly offset by strong revenue contributions of the Health Solutions and Wealth Solutions businesses.
Arthur J. Gallagher (AJG) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q2 results reflect higher commissions, fees, supplemental revenues and adjusted EBITDAC margin expansion across the segments, partially offset by higher expenses.
Willis Towers (WTW) Q2 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Willis Towers (WTW) Q2 results reflect strong revenue contribution from the Health, Wealth & Career and Risk & Broking segments, as well as expanded margin, offset by higher expenses.
What's in Store for Arthur J. Gallagher (AJG) in Q2 Earnings?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) second-quarter results are likely to reflect strong retention, higher new business, increasing renewal premiums, mergers and acquisitions and higher interest income.
Is a Beat in the Cards for Willis Towers (WTW) in Q2 Earnings?
by Zacks Equity Research
Willis Towers' (WTW) second-quarter performance is likely to have benefited from increased software sales, higher levels of Retirement work and new business activity.
Marsh & McLennan (MMC) Q2 Earnings Beat on Solid Marsh Unit
by Zacks Equity Research
Marsh & McLennan's (MMC) second-quarter results benefit on strong international operations and sound contribution from Health and Wealth businesses.
Marsh & McLennan (MMC) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Marsh & McLennan (MMC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Marsh & McLennan (MMC) Q2 Earnings Beat Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 0.84% and 0.96%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Towers Watson and Brown & Brown
by Zacks Equity Research
Marsh & McLennan, Aon, Arthur J. Gallagher, Willis Towers Watson and Brown & Brown have been highlighted in this Industry Outlook article.
5 Insurance Brokerage Picks to Gain From Increased Demand
by Sushmita Sarker
The increased demand for insurance products, given an aging population, baby boomers and millennials, and accelerated digitization, should drive insurance brokers like MMC, AON, AJG, WTW and BRO.
Will High Costs Weigh on Marsh & McLennan's (MMC) Q2 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) second-quarter results are likely to reflect strong performance in all segments amid higher operating expenses.
Brown & Brown (BRO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Brown & Brown (BRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Buy Marsh & McLennan (MMC) Following Dividend Hike?
by Zacks Equity Research
This increase reflects Marsh & McLennan's (MMC) 14th consecutive year of dividend increases and underscores its commitment to returning capital to shareholders.